Cargando…
Platelet-Derived GARP Induces Peripheral Regulatory T Cells—Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis
SIMPLE SUMMARY: Thrombocytosis correlates with poor prognosis for treatment of malignant melanoma. Detailed information on how platelets modify the anti-tumoral immune response is still elusive. Analyzing the immunomodulatory capacities of platelets on huCD4(+) T cells in vitro, we were able to show...
Autores principales: | Zimmer, Niklas, Krebs, Franziska K., Zimmer, Sophia, Mitzel-Rink, Heidrun, Kumm, Elena J., Jurk, Kerstin, Grabbe, Stephan, Loquai, Carmen, Tuettenberg, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762193/ https://www.ncbi.nlm.nih.gov/pubmed/33291452 http://dx.doi.org/10.3390/cancers12123653 |
Ejemplares similares
-
Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
por: Krebs, Franziska K., et al.
Publicado: (2021) -
GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity
por: Zimmer, Niklas, et al.
Publicado: (2022) -
GARP Regulates the Immune Capacity of a Human Autologous Platelet Concentrate
por: Trzeciak, Emily R., et al.
Publicado: (2022) -
GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme
por: Zimmer, Niklas, et al.
Publicado: (2019) -
Long-lasting tumor response on short-time administration of vemurafenib—A case report
por: Mitzel, Heidrun, et al.
Publicado: (2014)